SFX by Ex Libris Inc.

Title:	CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
Source:	Science [0036-8075] Bidinosti, M yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Glickman, G. "Vaccination Rates among Younger Siblings of Children with Autism." The New England Journal of Medicine 377.11 (2017): 1099-1101.
description	2.	Kwok, J. "Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome." Proceedings of the National Academy of Sciences of the United States of America 111.27 (2014): 9941-9946.
description	3.	Lois, C. "Retroviruses as tools to study the immune system." Current opinion in immunology 13.4 (2001): 496-504.
description	4.	Zerbo, O. "Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder." JAMA pediatrics 171.1 (2017): 163609-7.
description	5.	Goin Kochel, Robin P. "Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset?" Vaccine 34.11 (2016): 1335-1342.
description	6.	Eslick, Guy L. "Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies." Vaccine 32.29 (2014): 3623-3629.
description	7.	Miyoshi, H. "Development of a self-inactivating lentivirus vector." Journal of virology 72.10 (1998): 8150-7.
description	8.	Richler, J. "Is There a 'Regressive Phenotype' of Autism Spectrum Disorder Associated with the Measles-Mumps-Rubella Vaccine? A CPEA Study." Journal of Autism and Developmental Disorders 36.3 (2006): 299-316.
description	9.	Symons, Frank J. "Functional communication training in rett syndrome: a preliminary study." American journal on intellectual and developmental disabilities 119.4 (2014): 340-350.
description	10.	Khwaja, Omar S. "Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome." Proceedings of the National Academy of Sciences of the United States of America 111.12 (2014): 4596-4601.
description	11.	Pfeifer, A. "Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging." Molecular therapy 3.3 (2001): 319-22.
description	12.	Baltimore, D. "Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors." Science 295.5556 (2002): 868-872.
description	13.	Smith, Jr, E. "CORRECTION." JAMA 297.10 (2007): 1062-1466.
description	14.	Aleksic, N. "Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder." Vaccine 33.21 (2015): 2511-6.
description	15.	Turville, C. "Autism and vaccination: The value of the evidence base of a recent meta-analysis." Vaccine 33.42 (2015): 5494-5496.
description	16.	Uno, Y. "The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: The first case-control study in Asia." Vaccine 30.28 (2012): 4292-4298.
description	17.	Miller, L. "Autism and vaccination-the current evidence." Journal for Specialists in Pediatric Nursing 14.3 (2009): 166-72.
description	18.	Waight, P A A. "Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association." The lancet 353.9169 (1999): 2026-9.
description	19.	Shimizu, M. "No effect of MMR withdrawal on the incidence of autism: a total population study." Journal of child psychology and psychiatry and allied disciplines 46.6 (2005): 572-9.
description	20.	Taylor, B. "Vaccines and the changing epidemiology of autism." Child care, health and development 32.5 (2006): 511-519.